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Abstract
Background: The activation of innate immune responses by Plasmodium vivax results in activation of effector cells and an
excessive production of pro-inflammatory cytokines that may culminate in deleterious effects. Here, we examined the
activation and function of neutrophils during acute episodes of malaria.
Materials and Methods: Blood samples were collected from P. vivax-infected patients at admission (day 0) and 30–45 days
after treatment with chloroquine and primaquine. Expression of activation markers and cytokine levels produced by highly
purified monocytes and neutrophils were measured by the Cytometric Bead Assay. Phagocytic activity, superoxide
production, chemotaxis and the presence of G protein-coupled receptor (GRK2) were also evaluated in neutrophils from
malaria patients.
Principal Findings: Both monocytes and neutrophils from P. vivax-infected patients were highly activated. While monocytes
were found to be the main source of cytokines in response to TLR ligands, neutrophils showed enhanced phagocytic
activity and superoxide production. Interestingly, neutrophils from the malaria patients expressed high levels of GRK2, low
levels of CXCR2, and displayed impaired chemotaxis towards IL-8 (CXCL8).
Conclusion: Activated neutrophils from malaria patients are a poor source of pro-inflammatory cytokines and display
reduced chemotactic activity, suggesting a possible mechanism for an enhanced susceptibility to secondary bacterial
infection during malaria.
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Introduction
Malaria is a complex disease that affects approximately 300
million people every year. Among the different Plasmodium species
that infect humans, P. falciparum is the main cause of deaths in sub-
Saharan Africa. On the other hand, P. vivax is responsible for
approximately 60–80% of the malaria cases in the world [1,2], and
contributes to significant political, social and economic instability
in the developing countries of Latin America and Asia [1].
The innate immune system recognizes Plasmodium sp. by
different pattern-recognition receptors and initiates a broad
spectrum of defense mechanisms that mediate host resistance to
infection [3,4]. However, the innate immune response is the classic
‘‘two-edged sword’’, and clinical malaria is associated with high
levels of circulating pro-inflammatory cytokines. The outcome of
infection depends on a balance between pro- and anti-inflamma-
tory responses allowing the formation of an effective immune
response, while limiting its pathogenic potential [5,6,7].
Toll like receptors (TLR) play an important role in recognition of
pathogens through distinct pathogen-associated molecular pat-
terns (PAMPs). Activation of TLR on monocytes, dendritic cells
and neutrophils can induce changes in the expression of surface
proteins and release inflammatory mediators such as cytokines and
chemokines. The production of cytokines amplifies innate immune
responses and shapes the development of acquired immunity. In
addition, activated myeloid cells release high levels of reactive
oxygen species (ROS) and antimicrobial peptides that efficiently
kill invading pathogens [8,9].
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It is noteworthy that glycosylphosphatidylinositol anchors and
DNA from Plasmodium parasites are important PAMPs that
activate TLR during malaria [10,11,12,13]. Some in vitro studies
show that phagocytosis of opsonized hemozoin (HZ) decreases
expression of HLA-DR in monocytes [14,15]. On the other hand,
study has demonstrated that DNA bound to HZ induces
monocytes to produce high levels of cytokines and contribute to
dendritic cell maturation [16]. While other report evaluated
activation of polymorphonuclear cells and observed elevated levels
of myeloperoxidase, lysozyme and lipocalin in patients with severe
malaria [17], the involvement of neutrophils in malaria patho-
genesis has been poorly investigated.
Our findings show that both monocytes and neutrophils are
highly activated during malaria. Monocytes produced high levels
of IL-1b, IL-6 and TNF-a in response to TLR agonists during
acute malaria and seem to be the main source of pro-inflammatory
cytokines in the blood. On the other hand, neutrophils were a poor
source of cytokines, but displayed an enhanced phagocytic activity
and superoxide production. Interestingly, we noticed an enhanced
expression of G-protein receptor protein kinase (GRK2) associated
with decreased levels of CXCR2 and impaired chemotaxis of
neutrophils towards an IL-8 (CXCL8) gradient. Our findings
indicate a mechanism by which malaria patients may become
more susceptible to bacterial infection.
Methods
Ethics statement
All protocols and consent forms were approved by the
Institutional Research Board from University of Massachusetts
Medical School (IRB-UMMS 10268), the Ethical Committees on
Human Experimentation from Centro de Pesquisa em Medicina
Tropical (CEP-CEPEM 095/2009) and Centro de Pesquisas Rene´
Rachou – Fundac¸a˜o Oswaldo Cruz (CEP-CPqRR 2004), as well
as by the National Ethical Committee (CONEP 15652) from
Ministry of Health, Brazil. A signed informed consent was
obtained from each subject prior to enrollment in the study.
Patients
Patients were recruited and examined at CEPEM in Porto
Velho, a malaria endemic area in the Amazon region of Brazil. Up
to 100 ml of peripheral blood was collected immediately after
confirmation of P. vivax infection by thick blood smear film and
30–45 days after chemotherapy (n = 26, ranging from 18 to 66
years old [3569.5]). Patients were treated for 10 days with
chloroquine and primaquine. P. vivax infection was confirmed by
polymerase chain reaction (PCR) analysis [18]. The clinical
manifestations of malaria were fever, myalgia, chills, arthralgia,
nausea, vomiting or diarrhea, but no patient had complicated
malaria. Peripheral blood was also collected from 15 healthy
donors (HD) ranging from 21 to 56 years old [3268] living Porto
Velho and negative for P. vivax infection by thick blood film and
PCR. All the experiments were done using fresh cells.
Cellular immunophenotyping
Whole blood was stained with antibodies from ebioscience: anti-
CD14-FITC (clone 61D3), anti-TLR2-PE (clone T2.5), anti-
TLR4-PE (clone HTA125), anti-HLA-DR-PE (clone L243), anti-
CD14-APC (clone 61D3), anti-CD62L-APC (clone DREG56); BD
Bioscience-Pharmingen: anti-CD66b-FITC (clone G10F5), anti-
CD88-PE (clone C85-4124), CXCR2-PE (clone 6C6), anti-CD16-
PercpCy5.5 (clone3G8), anti-CD15-FITC (clone HI98); R&D:
CCR2-PE (clone 48607) Subsequently, red blood cells (RBC) were
lysed with FACS lysing solution (BD Biosciences) following
manufacturer’s instructions, washed with phosphate buffered
saline (PBS) and maintained in paraformaldehyde 2% (PFA) until
the acquisition on an FACScan upgraded with a second laser (5
colors). The software used for acquisition was CellQuest Pro from
BD and Rainbow from Cytek. Data analyzed using FlowJo version
9.3.2 (TreeStar)
Purification of monocytes and neutrophils
Peripheral blood mononuclear cells (PBMC) and neutrophils
were enriched on-site by gradient centrifugation over Ficoll-
PaqueTM plus (GE-Healthcare). Isolated PBMC were washed
twice in RPMI, ressuspended at 56107/ml in PBS supplemented
with 2% heat- inactivated fetal bovine serum (FBS) and 1 mM
EDTA. Monocytes were purified from PBMC with the Human
Monocyte Enrichment Kit (STEMCELL-Technologies) following
manufacturer’s instructions. The cell layer containing the granu-
locytes were collected just above the red blood cells phase and the
cell suspension was lysed with NH4Cl 0.15 M with KHCO3 0.1 M
and Na2EDTA 0.1 mM. Cells were ressuspended in PBS (2% FBS,
1 mM EDTA) at final concentration 56107/ml. Purification of
neutrophils were performed with the Human Neutrophil Enrich-
ment Kit (STEMCELL-Technologies) following manufacturer’s
instructions. Purity of monocytes and neutrophils was measured by
flow cytometry after staining with mAbs specific for CD14, CD66b
and CD16. Purified monocytes were CD14+CD162CD66b2 and
neutrophils were CD142CD16+CD66b+. Cell preparations reached
over 98% of purity and viability of 90–100%.
Tissue culture assays
Purified monocytes and neutrophils were plated in 96-well cell
culture plates at a final concentration 26105/well in RPMI1640
(Sigma Aldrich R6504) (10% FBS and 100 mg/ml streptomycin/
100 U/ml penicillin) in the presence or absence of Toll like receptors
agonists: 100 ng/ml lipopolysaccharide (LPS - TLR4 agonist,
Sigma-Aldrich) or 100 ng/ml Pam2CSK4 (Pam - TLR2/TLR1
agonist, InvivoGen). Supernatants were harvested after 48 hours
of culture and kept at 220uC until cytokine measurement.
Author Summary
Plasmodium vivax is responsible for approximately 60–80%
of the malaria cases in the world, and contributes to
significant social and economic instability in the develop-
ing countries of Latin America and Asia. The pathogenesis
of P. vivax malaria is a consequence of host derived
inflammatory mediators. Hence, a better understanding of
the mechanisms involved in induction of systemic inflam-
mation during P. vivax malaria is critical for the clinical
management and prevention of severe disease. The innate
immune receptors recognize Plasmodium sp. and initiate a
broad spectrum of host defense mechanisms that mediate
resistance to infection. However, the innate immune
response is the classic ‘‘two-edged sword’’, and clinical
malaria is associated with high levels of circulating pro-
inflammatory cytokines. Our findings show that both
monocytes and neutrophils are highly activated during
malaria. Monocytes produced high levels of IL-1b, IL-6 and
TNF-a during acute malaria. On the other hand, neutro-
phils were a poor source of cytokines, but displayed an
enhanced phagocytic activity and superoxide production.
Unexpectedly, we noticed an impaired chemotaxis of
neutrophils towards an IL-8 (CXCL8) gradient. We pro-
posed that neutrophil paralysis is in part responsible for
the enhanced susceptibility to bacterial infection observed
in malaria patients.
Neutrophil Paralysis in Malaria
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Cytokine measurements
IL-8 (CXCL8), IL-1b, IL-6, IL-10 and TNF-a were quantified
in cryopreserved plasma and supernatants from monocyte and
neutrophil cultures using the Cytometric Bead Array kit (CBA,
BD Biosciences Pharmingen) following manufacturer’s instruc-
tions. The limits for cytokine detection were 3.6 pg/ml (IL-8),
7.2 pg/ml (IL-1b, 2.5 pg/ml (IL-6), 3.3 pg/ml (IL-10) and
3.7 pg/ml (TNF-a).
Phagocytosis and superoxide assays
Phagocytosis was assessed by incubating neutrophils for 20 min
with opsonized zymosan (56106 particles/cell) in a glass slide.
Cells were stained by the May-Gru¨nwald-Giemsa (Rosenfeld)
method (Laborclin Pinhais, PR, BR). The number of cells
containing phagocytic vacuole was determined by counting 100
neutrophils. Nitro Blue Tetrazolium (NBT) assay was performed
using peripheral blood. Briefly, 25 ml of blood sample were added
to the same volume of NBT (1 mg/ml) at 37uC for 15 min and an
additional 15 min at room temperature. Percentage of cells
reducing NBT was established by counting 100 neutrophils.
Chemotaxis assay
Chemotaxis was performed with purified neutrophils using a 48-
well microchamber (NeuroProbe, Gaithersburg, MD) with a 5 mm
pore polycarbonate membrane. Fifty thousand neutrophils were
allowed to migrate toward IL-8 (CXCL8) (10 ng/ml), CCL2
(1 ng/ml), or medium alone. After 1 h incubation, at 37uC with
5% CO2 the membrane was removed, fixed and stained. The
number of neutrophils that migrated through the membrane was
counted under a light microscope on at least 5 randomly selected
fields.
Real-Time PCR
Total RNA from neutrophils was extracted using the Trizol
reagent (Invitrogen, Carlsbad, CA). Total RNA to cDNA was
carried out by reverse transcription (Superscript II, Gibco Life
Technologies Grand Island, NY). Real Time PCR (qPCR) analysis
of CXCR2 receptor mRNA profile was performed with the
Platinum SYBRH Green qPCR SuperMix-UDG kit (Invitrogen-
Life Technologies, USA) and the reactions were processed in ABI
Prism 7500 equipment (Applied Biosystems, Warrington, UK) was
performed in an ABI Prism 7500. The reactions were carried out
in a final volume of 10 ml containing 6.25 ml of SYBR Green,
0.5 mM of each primer (designed on the basis of the mRNA
sequence of the receptor gene available at the GenBank) and 1 ml
of cDNA. RT-PCR cycles were 95uC for 15 s and 60uC for
1 minute and the dissociation curve was constructed by increasing
temperatures from 60uC to 90uC. The primers used were:
CXCR2 sense: 59- AGATGCTGAGACATATGAATTT -39
and CXCR2 antisense: 59- CTTTTCTACTAGATGCCGC-39,
b-Actin sense: 59-GCTCGTCGTCGACAACGGCTC -39 and b-
Actin antisense: 59- CAAACATGATCTGGGTCATC -39. The
expression of b-actin mRNA was used as a control for all samples.
The relative level of gene expression was determined by the
comparative threshold cycle (Ct) method using the formula
22DDCt whereby data for each sample were normalized to b-
actin mRNA levels.
Immunofluorescence assay for GRK2
Neutrophils purified on glass slides were fixed with 4%
paraformaldehyde in a wet chamber at room temperature. Cells
were fixed with 4% paraformaldehyde, permeabilized with 0.2%
Triton X-100 (Amersham Pharmacia Biotech, CA) and blocked
with 1% bovine serum albumin (Sigma-Aldrich) in PBS containing
normal goat serum (1:50). Cells were then incubated overnight
with polyclonal rabbit anti-GRK-2 antibody (1:200, clone C-15,
Santa Cruz Biotechnology) followed by incubation with red
fluorescent Alexa Fluor 594 (goat anti-rabbit IgG (H+L); 1:400,
Life Technologies). Nuclear material was stained with 4, 6-
diamidino-2-phenylindole (DAPI; Sigma-Aldrich). Images of
stained cells were captured using an epi-fluorescence microscope
(BX-40; Olympus, Japan). The mean fluorescence intensity was
determined from a linear measurement of fluorescence of
individual cells using Image J software (Imaging process and
analysis in Java, National Institute of Mental Health). Ten cells of
five randomly chosen fields of each slide were analyzed.
Statistical analysis
Statistical analysis was performed using Prism software, version
5.0 (GraphPad). The results were analyzed using two-tailed paired
test. Wilcoxon testing was used when data did not fit a Gaussian
distribution. The results were analyzed using unpaired t test when
two groups were compared. Mann-Whitney (MW) test was used
when a normality test failed. Differences were considered to
statistically significant, when p#0.05.
Results
High levels of circulatory cytokines in P. vivax malaria
patients
High levels of the pro-inflammatory cytokines, IL-1b, IL-6, IL-
8, were found when comparing the sera from the same patients
presenting the active disease and after anti-malarial therapy and
parasitological cure or to HD. (Figure 1). The levels of TNF-a in
the sera did not differ significantly. The levels of IL-10 were also
higher before treatment than after parasitological cure. No
significant differences in the level of circulating cytokines were
found between HD (IL-8 median: 9.8; interquartile (IQR): 1.8- 21;
IL-1b median: 0.2 IQR: 0.13–2.8; IL-6 median: 0.14; IQR:0–5;
IL-10 median: 0–7.1; IQR: 0–7 and TNF-a median: 5.4; IQR 0–
21) and malaria patients who had completed the chemotherapy.
Monocytes and neutrophils activation during P. vivax
infection
The expression of various activation markers was analyzed on
monocytes (Figure 2A) and neutrophils (Figure 2B). Monocytes
were gated taking in consideration the expression of CD14, as
shown in the representative density plot (Figure 2A). Lower
expression of HLA-DR (median fluorescence intensity-MFI) was
observed on monocytes from 9 out of 12 P. vivax-infected patients,
when compared to the same patients after anti-malarial
treatment. To assess the neutrophil population, CD66b+CD16+
cells were gated. As CD66b is GPI-anchores highly glycoslated
protein, widely expressed on human neutrophils and to regulate
neutrophil acitvation. Lower levels of CD62L (8 out of 12
subjects) and CD88 (all patients) were found on neutrophils from
malaria patients before treatment (Figure 2B). The lower
expression of HLA-DR as well as CD62L is a cell adhesion
molecule, and CD88 is a G protein-coupled receptor for C5a,
have been previously described in activated monocytes and
neutrophils, respectively [14,19]. The levels of these activation
markers return to normal levels (comparable to the median of
HD (monocytes: HLA-DR (median: 278; IQR: 143–323);
neutrophils: CD88 (median: 27; IQR: 17–32) and CD62L
(median: 601; IQR: 439–666); in cells from P. vivax-patients
submitted to anti-malarial therapy.
Neutrophil Paralysis in Malaria
www.plosntds.org 3 June 2012 | Volume 6 | Issue 6 | e1710
Monocytes are a major source of cytokines during P.
vivax malaria
The expression of TLR2 was lower on both monocytes (8 out of
11 subjects) and neutrophils (10 out of 11 subjects) from malaria
patients, whereas expression of TLR4 was only affected on
neutrophils (8 out of 12) from infected individuals (Figures 2A
and 2B). After parasitological cure, the surface expression of TLR
returned to levels comparable to cells from HD (monocytes: TLR2
(median: 256; IQR: 241–276) and TLR4 (median: 11; IQR: 9–17;
neutrophils: TLR2 (median 46; IQR: 36–62) and TLR4 (median:
3.5; IQR: 2.9–6.4)). Two millions per ml (26105/well) of highly
purified monocytes or neutrophils were cultured with or without
TLR agonists and cytokines measured in the tissue culture
supernatants (Figure 3A and B). Cell preparations reached over
98% of purity, as shown in the representative dot plots presented
in Figure 3. Except for IL-8, neutrophils were over all a poor
source of cytokines. No detectable levels of IL-1b, IL-6, IL-10 and
TNF-a were found in culture supernatants of neutrophils
stimulated or not with LPS or Pam (Figure 3B), even when
neutrophils were used at a concentration of 16107/ml (16106/
well). On the other hand, upon stimulation with LPS or Pam, high
levels of IL-1b, IL-6, and TNF-a were produced by monocytes
from malaria patients. (Figure 3A). Interestingly, the levels of
LPS-induced IL-10 were lower in culture supernatants of
monocytes derived from patients with ongoing P. vivax infection.
After parasitological cure the cytokine production by monocytes
returned to levels comparable to those produced by monocytes
from HD (median: 1692; IQR: 1200–5265). IL-8 (CXCL8) was
the only cytokine produced in high levels by neutrophils. Despite
the down-modulation of TLR2 and TLR4, stimulation with TLR
agonists increased the levels of IL-8 produced by neutrophils
(Figure 3B) from malaria patients before (medium versus LPS,
p=0.0010 or Pam, p=0.0024) and after treatment (medium vs
LPS, p=0.0002; or Pam, p=0.0017). IL-8 was also produced by
monocytes and the levels of cytokine did not differ between
patients, before and after treatment (Figure 3A).
Enhanced oxidative and phagocytic activity by
neutrophils from malaria patients
The O2
2 production by neutrophils was increased during acute
malaria (Figure 4). Higher percentage of NBT positive cells was
observed in the blood of P. vivax-infected patients (Figure 4, left
panel). The function of neutrophils was further investigated by
assessing their phagocytic activity, which was also higher in cells
from P. vivax-infected individuals (Figure 4, right panel).
Impaired chemotaxis by neutrophils from malaria
patients
The ability of purified neutrophils to migrate towards CXCR1,
CXCR2 and CCR2 ligands (IL-8 and CCL2) was evaluated by
using a modified Boyden chamber assay [20]. Neutrophils from
malaria patients showed impaired chemotaxis to IL-8, when
compared to HD (median: 31; IQR: 28–39) (Figure 5A). The
poor migration of neutrophils from malaria patients was associated
with decreased expression of the chemokine receptor CXCR2, as
indicated by qPCR (Figure 5C) and FACS (Figure 5B).
Chemotaxis to CCL2 and expression of CCR2 by neutrophils
were minimal and not altered in malaria patients (Figures 5A
and 5B).
Enhanced expression of GRK2 in neutrophils from malaria
patients
GRK2 has been described to down-modulate expression of
chemokine receptors. Importantly, continuous and excessive
activation of neutrophils results in an increased expression of
Figure 1. High levels IL-1b IL-6, IL-8 and IL-10 in plasma from patients infected with P. vivax. The cytokines IL-8 (CXCL8), IL-1b, IL-6, IL-10,
TNF-a were measured in the plasma of P. vivax-infected subjects (n = 26), before (closed circles) and 30–45 days after treatment (open circles). Dotted
lines represent medians of given measurements from healthy donors (HD; n = 13). Levels of cytokines were measured employing the Cytometric Bead
Array (CBA). Significant differences are indicated with p-values using Wilcoxon signed rank test when the data failed the normality test.
doi:10.1371/journal.pntd.0001710.g001
Neutrophil Paralysis in Malaria
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GRKs, which phosphorylate G protein–coupled receptors (GPCR)
leading to receptor desensitization [21]. GRK2 expression was
measured by immunofluorescence in neutrophils purified from
blood of P. vivax-infected patients and HD (median: 12.6; IQR:
4.7–23). Compared with HD, a significant increase in GRK2
expression was observed in neutrophils from P. vivax-infected
patients (Figure 6A and 6B).
Discussion
The pathogenesis of P. vivax malaria is a consequence of host
derived inflammatory mediators [1,22]. Hence, a better under-
standing of the mechanisms involved in induction of systemic
inflammation during P. vivax malaria is critical for the clinical
management and prevention of severe disease. Neutrophils are the
most abundant leukocyte population in the peripheral blood and
thus being in direct contact with red blood cells, the main cells
population that is parasitized by Plasmodium species. Surprisingly,
very few studies have addressed the role of the polymorphonuclear
cells (PMNs) during malaria. In this study, we investigated the
activation and function of neutrophils during acute episodes of P.
vivax malaria. Neutrophils were shown to be highly activated
presenting enhanced phagocytic activity as well as superoxide
production. In contrast, neutrophils were found to be poor sources
of cytokines during malaria. It is noteworthy that we described for
the first time an impaired chemotaxis by circulatory neutrophils
from malaria patients. Importantly, different studies have
described an association of severe malaria and bacterial infections
[23,24]. Thus, our results suggest that the failure of neutrophils to
migrate to the sites of infection may represent an important
mechanism that leads to enhanced susceptibility of malaria
patients to secondary bacterial infections.
We first noticed that both circulatory neutrophils (decreased
expression of CD62L and CD88) and monocytes (decreased
expression of HLA-DR) from malaria patients were highly
activated. We then asked, what would be the primary source of
Figure 2. Systemic activation of monocytes and neutrophils during P. vivax malaria. Mean fluorescence intensity (MFI) of HLA-DR, TLR2
and TLR4 was evaluated on monocytes (A) and CD62L, CD88, TLR2 and TLR4 on neutrophils (B) in whole blood from P. vivax-infected subjects (n = 12),
before (closed circles) and 30–45 days after treatment (open circles). Representative density plots showing the gate strategy for monocytes CD14+ (A)
and neutrophils CD66b+CD16+ (B) are shown. Significant differences are indicated with p-values using Wilcoxon signed rank test when the data failed
the normality test.
doi:10.1371/journal.pntd.0001710.g002
Neutrophil Paralysis in Malaria
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pro-inflammatory cytokines during P. vivax-malaria? We found
that in the blood, monocytes are an important source of cytokine
compared with neutrophils. Despite the fact that neutrophils are
an important source of cytokines [25], we found that except for IL-
8 (CXCL8), the neutrophils from malaria patients produced none
or very small amounts of pro-inflammatory cytokines (i.e., IL-1b,
IL-6, and TNF-ain response to TLR agonists. Importantly,
PBMCs from individuals experimentally or naturally infected
with P. falciparum are hyperresponsive and produce high amounts
of pro-inflammatory cytokines once activated with TLR agonists
[6,7]. Here, we observed that highly purified monocytes (but not
neutrophils) derived from P. vivax malaria patients were primed
and produce high levels of IL-1b, IL-6 and TNF-a upon TLR
stimulation. In contrast, the monocytes from malaria patients
produced low levels of IL-10, even when activated with TLR
agonists. Thus, we favor the hypothesis that during malaria
monocytes differentiate into an inflammatory stage producing high
levels of pro-inflammatory cytokines and low levels of IL-10.
On the other hand, circulatory neutrophils from malaria-
patients displayed enhanced phagocytic activity and constitutively
released high levels of superoxide. The process of neutrophil
activation could involve phagocytosis of opsonized parasites, which
would in turn trigger the antibody dependent respiratory burst
[26]. Alternatively, phagocytosis of the malaria pigment (hemo-
zoin) may also activate neutrophils [27]. The enhanced effector
function of neutrophils may account for a more efficient up-take
and destruction of free parasites and infected erythrocytes [26].
On the other hand, activated neutrophils have been shown to
cause damage of endothelial cells, in a process that is mediated by
sera of malaria patients [28]. Therefore, enhanced effector
functions in neutrophils could be involved in both host resistance
and pathogenesis of P. vivax malaria.
Unexpectedly, we found an altered migration towards IL-8
gradient, which was associated with a decreased expression of
CXCR2 on neutrophils from P. vivax-infected patients. Functional
studies showed that upon phagocytosis of bacteria by neutrophils
there is reduction in expression of CXCR1 and CXCR2 [29].
Down-regulation of CXCR2 in severe sepsis also results in failure
of neutrophil migration that is associated with enhanced suscep-
tibility to bacterial infection [30]. Furthermore, expression of
CD88 (C5a receptor) and CD62L (L-selectin) is decreased on the
surface of neutrophils from P. vivax-malaria patients. CD88 is a G
protein-coupled receptor involved in recruitment [19,31], whereas
CD62L is a key molecule that mediates cytoadherence of
leukocytes [32]. Thus, altogether, our data strongly suggest that
systemic activation neutrophils, leads to failure of extravasation
and chemotaxis from blood to the tissues. Since IL-8 mediates
chemotaxis and stimulate neutrophils to release specific granules
and proteases to fight microbial infections [33,34], the impairment
of neutrophil migration to the site of infection would prevent front
line cells to promote an inflammation to effectively kill infectious
pathogens allowing secondary infections.
Production of IL-8 has been assessed in several cell type upon
stimulation, several medical conditions and even constitutively
[35,36,37]. The observed high levels of circulatory IL-8 may
mediate desensitization and/or down-regulation of CXCR2 in
acutely infected malaria patients. In addition, TNF-a [38], nitric
oxide [30], heme-oxygenase products [39] and TLR ligands
[20], cause the heterologous desensitization of CXCR2 via
GRK2 induction. As previous described in vivax malaria [40,41],
we did not find a high level of TNFa in serum, the monocyte
stimulated with TLR agonists produced high amounts of TNF-a
Figure 4. Neutrophils from P. vivax-infected patients produce
high levels of superoxide and display enhanced phagocytic
function. Neutrophils were isolated from P. vivax-infected patients
(closed circles; n = 15) or healthy donors (open circles; n = 15), and the
frequencies of neutrophils reducing NBT (left panel) as well as cell
containing zymosan (right panel) were quantified. Significant differenc-
es are indicated with p-values using unpaired t test or Mann-Whitney
test when a normality test failed.
doi:10.1371/journal.pntd.0001710.g004
Figure 3. TLR agonists induce production of high IL-1b, IL-6 and TNF-a levels by monocytes from P. vivax-infected subjects. Purified
monocytes (A) or neutrophils (B) from P. vivax-infected subjects before (closed circles; n = 13) and 30–45 days after treatment (open circles; n = 13)
were cultured for 48 hours in the absence or presence of LPS or Pam. Levels of IL-1b, IL-6, IL-10, TNF-a, and IL-8 (CXCL8) were measured in
supernatant of monocyte (A) and neutrophil (B) cultures. Levels of cytokines were measured employing the Cytometric Bead Array (CBA). Significant
differences are indicated p-values using paired t test or Wilcoxon signed rank test when a normality test failed.
doi:10.1371/journal.pntd.0001710.g003
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that may contribute to CXCR2 desensitization. In addition,
Plasmodium can be recognized by TLR2, TLR4 and TLR9
[10,42] and induce down-regulation of CXCR2 via GRK2.
Importantly, CD88 is also desensitized via GRK2 [43]. Thus,
decreased expression of CXCR2 and CD88 on neutrophils from
malaria patients may be a consequence of an enhanced
expression of GRK2.
GRKs constitute a group of serine/threonine protein kinases
that are key modulators of protein-coupled receptor signaling
(GPCR) [44]. A major mechanism for desensitization of activated
GPCR is their phosphorylation by GRKs [45]. Of note both
CD88 and CXCR2 are GPCRs. Deficient expression of GRK and
regulation of chemokine receptors in GRK2+/2 mice results in
enhanced migration of lymphocytes and chemotaxis toward
Figure 5. Malaria impairs neutrophils response to CXCR1 and CXCR2 ligand. Neutrophils were isolated from P. vivax-infected patients
(closed circles; n = 15) or healthy donors (open circles; n = 15), and chemotaxis towards IL-8 (CXCL8) and CCL2 was assessed (A). MFI of CXCR1, CXCR2
and CCR2 on neutrophils were evaluated by flow cytometry and representative histograms of CXCR2 expression are shown (B). CXCR2 message was
measured by qPCR (C). Significant differences are indicated with p-values using unpaired t test or Mann-Whitney test when a normality test failed.
doi:10.1371/journal.pntd.0001710.g005
Figure 6. GRK2 expression is enhanced in neutrophils during acute malaria. Neutrophils isolated from P. vivax-infected patients (closed
circles; n = 11) or healthy donors (closed circles; n = 12) were stained for GRK2 and mean fluorescence intensity (MFI) of GRK2 was quantified (A).
Representative fluorescence microscopy illustrating GRK2 expression in neutrophils from a healthy donor and a P. vivax-infected patient (B).
Significant difference is indicated with p-values using unpaired t test.
doi:10.1371/journal.pntd.0001710.g006
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CCL4, the CCR5 ligand [46]. It was also described that
transcription of GRK2 and GRK5 is upregulated upon LPS-
mediated activation, leading to reduced expression of chemokine
receptor and neutrophils chemotaxis [47]. GRK2 and GRK5
expression are enhanced in sepsis patients [48] and in rodent
models of severe sepsis [20], which are associated with impaired
migration of neutrophils and enhanced susceptibility to secondary
microbial infection.
For many years, P. vivax malaria was considered a benign and
self-limited disease, especially when compared to P. falciparum
infection [49]. However, recent studies highlighted the association
of P. vivax malaria with life-threatening manifestations, such as
respiratory distress, severe thrombocytopenia and anemia, as well
as neurological manifestations [1,22,50,51,52,53,54]. A main
hypothesis of our research group is that secondary infections, in
malaria primed individuals, is a main cause of severe disease. In
this regard, pro-inflammatory priming during malaria would result
in dramatic decrease in the threshold to initiate a septic shock [7],
due to an over-reaction to secondary infections, particularly in the
case of bacteria that have extremely potent TLR agonists.
Importantly, areas of the world with the highest incidence and
prevalence of malaria also have a high incidence of bacterial
infections, including Salmonella, Pneumococcus and Meningococcus
[23,55]. Furthermore, a recent study highlights that severe malaria
as indicated by respiratory distress, anemia and mortality, is 8.5
times more elevated in children with both malaria and bacteremia
as compared to infection with P. falciparum alone [24]. Thus, co-
infection with bacteria is not only common, but as we might
predict, it is an important factor influencing outcome of disease
and development of severe disease [24,56]. Here, we demonstrate
for the first time that circulatory neutrophils from malaria patients
display a decreased expression of chemokine receptors and
adhesion molecules, which culminates in impaired chemotaxis.
Hence, our results suggest that a failure of these PMNs to migrate
to peripheral tissues is an important mechanism leading to
enhance susceptibility to bacterial infection during malaria.
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